Remission of Paraneoplastic Dermatomyositis Associated with Hepatocellular Carcinoma under Prednisolone and Azathiopin, and Concommittant Sorafenib

Publisher： Karger

E-ISSN： 2296-5262|32|1-2|50-53

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.1-2, 2009-01, pp. : 50-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paraneoplastic Dermatomyositis in Hepatocellular Carcinoma with Colonic Perforation: A Case Report

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-09 ,pp. : 547-553

Karger

Access to resources Recommend Favorite

Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 85-92

Karger

Access to resources Recommend Favorite

Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 154-166

Karger

Access to resources Recommend Favorite

Spontaneous Remission of a Hepatocellular Carcinoma

By  

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-05 ,pp. : 156-159

Karger

Access to resources Recommend Favorite

The Germline BIM Deletion Polymorphism Is Not Associated with the Treatment Efficacy of Sorafenib in Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 85, Iss. 5, 2013-11 ,pp. : 312-316

Karger

Access to resources Recommend Favorite